According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...

The companies will deliver products for diabetes and weight control in specific nations across the Middle East.

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

A recent study found that tirzepatide, the active ingredient in Zepbound and Mounjaro, could reduce the risk of ...

Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

A new study suggests semaglutide drugs like Ozempic, used for type 2 diabetes, may lower the risk of opioid overdose in ...

Biocon said that it has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialize its GLP-1 products for treating diabetes and chronic weight management, ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Indian shares are set to open at fresh highs on Friday, riding the coattails of the outsized U.S. rate cut last week, with IT ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

to examine potential applications of glucagon-like peptide-1 receptor (GLP-1R) agonists in central nervous system disorders, such as dementia, Parkinson’s disease, substance and alcohol use disorders, ...